title: Letter from the editor.
authors.affiliation: Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
authors.forename: Ronald
authors.initials: R
authors.lastname: Ellis
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D002986:Clinical Trials as Topic; D003140:Communicable Disease Control / Q000191:economics / Q000379:methods*; D003141:Communicable Diseases / Q000191:economics / Q000453:epidemiology*; D055808:Drug Discovery / Q000639:trends*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D014612:Vaccines / Q000276:immunology* / Q000302:isolation & purification*
chemical_list: D014612:Vaccines